WeedMD Inc., a distributor of medical-grade cannabis, and Blockstrain Technology Corp. are pleased to announce the kick off the launch of Blockstrain’s proprietary genome tracking software. The announcement has come following the collection and registration of WeedMD’s cannabis plant DNA.
The Blockstrain solution is a company designed to expedite DNA testing of cannabis strains, and their registration in a blockchain-enabled database in order to protect the client’s intellectual property and bring actionable quality assurance to the cannabis industry. WeedMD is a federally-licensed producer and distributor of cannabis plant, dried flower and oil under the Access to Cannabis for Medical Purposes Regulations.
As Blockstrain’s first commercial client, WeedMD initially registered 40 out of hundreds of proprietary strains developed in-house. With this they can guarantee that consumers and WeedMD’s B2B customers are getting the cannabis strains they purchased.
“This is significant for our industry and our discerning consumers/customers that expect consistent products be delivered. We are proud to be the first company in Canada that can stand behind its products in a way that is transparent and verifiable,” said Keith Merker, CEO of WeedMD. “We can now confirm instantly through Blockstrain’s technology that our products are authentic and that customers are receiving high quality strains developed by WeedMD, verified as tested for quality and purity.”
“It was an amazing experience to be on hand for the launch of not only our software and genetics collection, but a new era in the development of legal cannabis in Canada,” said Robert Galarza, CEO of Blockstrain. “We are now able to provide consumers with an assurance of quality and can guarantee the provenance of the strains they are buying. Just as importantly, we can now create an immutable record for cannabis cultivators to protect the strains they develop.”